Rotateq vaccine 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FPA9B
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,578
Award facts
- Contract value 100% obligated
- $12,577.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $12,577.80 delivery order to Amerisourcebergen Drug Corp on May 4, 2026, for Rotateq vaccine (2 mL formulation).
The order is placed under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V indefinite delivery contract (SPE2DX), which supports worldwide military healthcare supply across multiple therapeutic domains. Place of performance is Conshohocken, PA. Ultimate completion is May 5, 2026. The order is priced firm fixed-price with no set-aside applied.
Quick answers
Who was awarded contract SPE2DR26FPA9B?
SPE2DR26FPA9B was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 4, 2026.
How much is contract SPE2DR26FPA9B worth?
The government has obligated $12,578 on SPE2DR26FPA9B.
Is contract SPE2DR26FPA9B an order under another contract?
Yes. SPE2DR26FPA9B is a delivery order under SPE2DR25D1021, an indefinite delivery contract.
Was contract SPE2DR26FPA9B competed?
The extent of competition for SPE2DR26FPA9B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award